ReviewInvestigational new drugs2026
Comparative efficacy of CLDN18.2-directed regimens in advanced gastric/gastroesophageal junction adenocarcinoma: a meta-analysis of single-arm trials.
Yue Yuan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.